Remedy Plan Therapeutics
Steve has been in the oncology clinical research field for 35 years, including over 12 years in the pharmaceutical industry. Steve is the Chief Medical Officer (CMO) of Shasqi, and previously held roles as the CMO at Vida Development Sciences and BioClin Therapeutics. He also previously served as Executive Director at Amgen, where he led global development efforts across clinical research and medical affairs.
This person is not in the org chart
This person is not in any offices
Remedy Plan Therapeutics
Remedy Plan is a biotechnology company developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.